company background image
A003060 logo

Aprogen Biologics KOSE:A003060 Stock Report

Last Price

₩1.90k

Market Cap

₩12.5b

7D

-5.9%

1Y

-46.0%

Updated

27 Mar, 2024

Data

Company Financials

Aprogen Biologics Inc.

KOSE:A003060 Stock Report

Market Cap: ₩12.5b

A003060 Stock Overview

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea.

A003060 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Aprogen Biologics Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aprogen Biologics
Historical stock prices
Current Share Price₩1,900.00
52 Week High₩7,240.00
52 Week Low₩1,560.00
Beta0.24
1 Month Change9.83%
3 Month Change-34.48%
1 Year Change-46.02%
3 Year Change-83.76%
5 Year Change-91.61%
Change since IPO-99.78%

Recent News & Updates

Recent updates

We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Jan 16
We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 20
Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Nov 24
Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Shareholder Returns

A003060KR PharmaceuticalsKR Market
7D-5.9%6.0%3.8%
1Y-46.0%28.8%13.0%

Return vs Industry: A003060 underperformed the KR Pharmaceuticals industry which returned 28.8% over the past year.

Return vs Market: A003060 underperformed the KR Market which returned 13% over the past year.

Price Volatility

Is A003060's price volatile compared to industry and market?
A003060 volatility
A003060 Average Weekly Movement12.4%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.3%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A003060's share price has been volatile over the past 3 months.

Volatility Over Time: A003060's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1960363Jeong-Chool Kimhttps://en.aprogen-pharm.com/index.do

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss.

Aprogen Biologics Inc. Fundamentals Summary

How do Aprogen Biologics's earnings and revenue compare to its market cap?
A003060 fundamental statistics
Market cap₩12.49b
Earnings (TTM)-₩118.27b
Revenue (TTM)₩87.36b

1.4x

P/S Ratio

-1.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A003060 income statement (TTM)
Revenue₩87.36b
Cost of Revenue₩99.34b
Gross Profit-₩11.97b
Other Expenses₩106.30b
Earnings-₩118.27b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.80k
Gross Margin-13.71%
Net Profit Margin-135.38%
Debt/Equity Ratio43.8%

How did A003060 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.